Supplemental FDA funding
This article was originally published in The Tan Sheet
Executive Summary
A version of the Supplemental Appropriations Bill of 2008, H.R. 2642, passed by the Senate would provide an additional $275 million for FDA, but would likely not receive President Bush's approval, the Office of Management and Budget says May 22. The president "has made clear that he will veto a bill that ... exceeds his responsible spending levels," according to OMB Director Jim Nussle. The Senate approved the measure May 15 with $100 million in additional FDA funding to regulate drugs, devices and biologics, $50 million to modernize its science and workforce, and $125 million for food protection as well as supplement support for other domestic measures, but a same-day approval by the House did not include the additional FDA funds (1"The Tan Sheet" May 19, 2008, p. 10)...